Cambrium Launches NovaColl: First Micro-Molecular & Skin-Identical Collagen Ingredient for Personal Care Industry

2023-03-24

The biotechnology company will debut its first product at the in-cosmetics Global trade show from March 28-30, in Barcelona NovaColl product image. (Credit: GlobeNewswire, Inc./ Cambrium) Biotechnology company Cambrium has launched its first product: NovaColl. It is the first micro-molecular & 100% skin-identical collagen specifically designed for premium personal care formulations. Owing to its structure and small molecular size, NovaColl is able to create powerful collagen benefits across skin layers. This new class of collagen active is vegan certified and produced through Cambrium’s precision fermentation process, offering formulators a unique combination of efficacy, skin-compatibility and sustainability. NovaColl’s claims have been scientifically validated in third party in vitro studies, which demonstrated a broad range of activities working to holistically protect, maintain and enhance native collagen. Beyond bio-similarity, NovaColl is 100% skin-identical, offering previously inaccessible levels of biocompatibility for personal care applications. To achieve this, Cambrium’s multi-disciplinary team of scientists and engineers searched through billions of protein sequences for skin-active features and indicators of efficacy. They identified NovaColl, a highly bioactive region of collagen I, the most prevalent collagen type in our human skin. Rather than extracting collagen from animals, Cambrium uses yeast cells to grow their micro-molecular collagen in a cruelty-free and sustainable fermentation process, minimizing energy, land, and water use. Source: Company Press Release

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构